First Tracks Biotherapeutics, Inc.·4

May 14, 4:05 PM ET

Ware J. Anthony 4

Research Summary

AI-generated summary

Updated

First Tracks (TRAX) Director Ware J. Anthony Receives 57,000-Share Award

What Happened

  • Director Ware J. Anthony was granted two derivative awards on May 12, 2026: 15,000 restricted stock units (RSUs) and an award of options covering 42,000 shares (57,000 total). Both grants were reported with $0.00 acquisition price (typical for RSU/option grants). These were awards/grants (A) rather than open‑market purchases or sales.

Key Details

  • Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (timely filing).
  • Grant amounts and reported prices: 15,000 RSUs @ $0.00; 42,000 options/derivative award @ $0.00.
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Notable footnotes from the filing:
    • F1: Each RSU represents a contingent right to receive 1 share upon settlement for no consideration.
    • F2: The RSUs vest 100% on the date of the Issuer’s 2027 annual meeting, subject to continued service.
    • F3: The stock option vests 1/12 monthly beginning June 12, 2026, subject to continued service.
    • F4: In addition to the 42,000-option grant, the reporting person holds additional options to purchase up to 131,585 shares that vest per their own terms.
  • Filing timeliness: The Form 4 was filed within the normal reporting window (no late filing indicated).

Context

  • RSUs are a contingent right to receive shares at settlement and do not involve an immediate cash purchase; they typically convert to shares when vested and settled.
  • The 42,000 award appears to be options that vest over time (monthly installments), not an immediate exercise or sale; exercise price is not specified in the provided details.
  • Awards/grants are common for compensation and retention and do not by themselves indicate buying/selling sentiment.